Global Fetal Bovine Serum Market

Fetal Bovine Serum Market Size, Share, Growth Analysis, By End-user(Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users), By Application(Biopharmaceutical Production, Monoclonal antibodies, Vaccines production, Other therapeutic proteins), By Type(Serum-free Media, CHO Media, HEK 293 Media, BHK Media), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35I2208 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 108 | Figures: 76

Fetal Bovine Serum Market Dynamics

Fetal Bovine Serum Market Drivers 

Rising Biopharmaceutical R&D Activity 

  • Surging use of monoclonal antibodies, vaccines, and cell therapies for the treatment of various diseases has resulted in high demand for biopharmaceutical research around the world. Fetal bovine serum is a key supplement in cell culture media required for biopharmaceutical production thereby making this a key fetal bovine serum market growth driver.  

High Investments in Stem Cell Research 

  • Growing demand for regenerative medicine and cell therapies have resulted in high investments in stem cell research around the world. Fetal bovine serum plays a crucial role in cultivation of different cell types in stem cell research thereby making it a vital component for any stem cell research project.  

Fetal Bovine Serum Market Restraints 

Ethical Concerns Regarding Animal Welfare 

  • The collection of fetal bovine serum involves the use of bovine fetuses, which raises ethical concerns among animal welfare organizations. A rising number of people taking objection to medical practices involving animals is adding to the ethical conundrum and thereby limiting the global fetal bovine serum market outlook going forward.  

Batch Variability Creating Inconsistency 

  • Fetal bovine serum is a natural product and derived straight from natural sources, which results in variations that cannot be controlled. These variations can result in inconsistency and thereby negatively affect experimental reproducibility and product quality as well. Hence, this variability in different fetal bovine serum batches is slated to slow down market development potential in the future. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Fetal Bovine Serum Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.79 billion in 2023 to USD 5.15 billion by 2031, by rising at a CAGR of 14.1% during the forecast period (2024-2031). 

Fetal bovine serum providers should focus on solving the ethical concerns surrounding the production of their product to maximize business scope. Targeting countries where investments in cell research are high is expected to offer better returns on investments for fetal bovine serum providers. Fetal bovine serum companies should also try to achieve consistency in different batches of fetal bovine serum to improve consistency of results.   'Thermo Fisher Scientific Inc. (US)', 'Merck KGaA (Germany)', 'GE Healthcare (US)', 'Tissue Culture Biologicals (US)', 'HiMedia Laboratories Pvt. Ltd. (India)', 'Atlanta Biologicals Inc. (US)', 'Sigma-Aldrich Corporation (US)', 'Rocky Mountain Biologicals (US)', 'PAN-Biotech GmbH (Germany)', 'Bovogen Biologicals Pty Ltd. (Australia)', 'Biowest SAS (France)', 'Biological Industries Israel Beit Haemek Ltd. (Israel)', 'Corning Incorporated (US)', 'Sera Laboratories International Ltd. (UK)', 'Caisson Laboratories Inc. (US)', 'Hyclone Laboratories Inc. (US)', 'Lanzhou Minhai Biotechnology Co., Ltd. (China)', 'Moregate BioTech (UK)', 'Gemini Bio-Products (US)', 'Lampire Biological Laboratories (US)'

Surging use of monoclonal antibodies, vaccines, and cell therapies for the treatment of various diseases has resulted in high demand for biopharmaceutical research around the world. Fetal bovine serum is a key supplement in cell culture media required for biopharmaceutical production thereby making this a key fetal bovine serum market growth driver.  

Use in 3D Cell Culture: Investments in 3D cell culture are increasing rapidly around the world and this is expected to present new opportunities for fetal bovine serum providers in the future. Fetal bovine serum can play a vital role in maintaining stability of complex 3D cell culture systems over the coming years and boost revenue generation potential for market players.   

North America is forecasted to account for a high fetal bovine serum market share on a global level. Rising healthcare research and development activity, growing emphasis on improving biopharmaceutical production, and presence of multiple pharmaceutical companies are key factors allowing this region to maintain its dominant stance. The United States is slated to spearhead revenue generation in North America followed by Canada over the coming years. Availability of supportive government funding for medical research and rising investments in stem cell and regenerative medicine research are also slated to create new opportunities for fetal bovine serum providers in this region.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Fetal Bovine Serum Market

Report ID: SQMIG35I2208

$5,300
BUY NOW GET FREE SAMPLE